Clinical Trial Update: Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating veliparib with carboplatin and etoposide in treatment-naive extensive-stage small cell lung cancer has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Veliparib (veliparib)

Snippet

Sponsor: AbbVie | Conditions: Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-05-14